Cornell Belcher, Brilliant Corners Research's founder and president, and Brian Gardner, Stifel's chief Washington policy ...
Stifel lowered the firm’s price target on Crispr Therapeutics (CRSP) to $53 from $59 and keeps a Hold rating on the shares following the ...
Eric Lyon, a former senior managing director, B. Riley Wealth Management, jumped to Kestra Investment Services at the start ...
will present a corporate overview at the Stifel Healthcare Conference, on November 18, 2024 at 1:50 p.m. ET in New York, NY ...
Stifel Nicolaus analyst Tore Svanberg maintained a Sell rating on Alpha and Omega (AOSL – Research Report) today and set a price target ...
Investment bank B. Riley Financial said on Friday it had agreed to sell a portion its traditional wealth management business ...
B. Riley Financial Inc. agreed to sell a portion of its wealth-management business to Stifel Financial Corp. for as much as ...
Take Raymond James Financial Inc. and Stifel Financial Corp., both of which reported quarterly earnings this week. Stifel ...
Stifel Financial reports decent Q3 2024 results with a +2% revenue beat. Learn more about SF stock and why it remains ...
Athletes, artists, beer tastings, movies and more highlight the 10-day Stifel Birds of Prey Audi FIS Alpine Ski World Cup at Beaver Creek Dec. 6-15. Complementing the on-hill action featuring the best ...
Stifel analyst Chris O’Cull downgraded Portillo’s (PTLO) to Hold from Buy with a $13 price target The company reported disappointing same-restaurant-sales and traffic performance, with EBITDA above ...